IL41666A - Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them - Google Patents
Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing themInfo
- Publication number
- IL41666A IL41666A IL41666A IL4166673A IL41666A IL 41666 A IL41666 A IL 41666A IL 41666 A IL41666 A IL 41666A IL 4166673 A IL4166673 A IL 4166673A IL 41666 A IL41666 A IL 41666A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- hereinbefore described
- compounds
- general formula
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2210650A DE2210650C3 (de) | 1972-03-06 | 1972-03-06 | 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE19722260860 DE2260860A1 (de) | 1972-12-13 | 1972-12-13 | Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL41666A0 IL41666A0 (en) | 1973-05-31 |
| IL41666A true IL41666A (en) | 1976-02-29 |
Family
ID=25762843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL41666A IL41666A (en) | 1972-03-06 | 1973-03-02 | Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3876646A (es) |
| JP (1) | JPS5626658B2 (es) |
| AT (1) | AT325614B (es) |
| CA (1) | CA985685A (es) |
| CH (1) | CH580591A5 (es) |
| CS (1) | CS179980B2 (es) |
| DD (1) | DD106832A5 (es) |
| DK (1) | DK135714C (es) |
| ES (1) | ES412320A1 (es) |
| FR (1) | FR2183673B1 (es) |
| GB (1) | GB1374551A (es) |
| HU (1) | HU167088B (es) |
| IE (1) | IE37367B1 (es) |
| IL (1) | IL41666A (es) |
| NL (1) | NL7303134A (es) |
| SE (1) | SE384206B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3951993A (en) * | 1972-03-06 | 1976-04-20 | Bayer Aktiengesellschaft | 2-Amino-4,5-dihydropyridine derivatives and process for their preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
| DE2013431C3 (de) * | 1970-03-20 | 1979-12-20 | Bayer Ag, 5090 Leverkusen | 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester |
| DE1963186C3 (de) * | 1969-12-17 | 1979-02-15 | Bayer Ag, 5090 Leverkusen | Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester |
| ZA7152B (en) * | 1970-01-24 | 1971-10-27 | Bayer Ag | New pharmaceutically active 1,4-dihydropyridines |
| DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2117572C3 (de) * | 1971-04-10 | 1980-03-20 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
-
1973
- 1973-02-23 DD DD169020A patent/DD106832A5/xx unknown
- 1973-02-28 US US336481A patent/US3876646A/en not_active Expired - Lifetime
- 1973-03-02 CH CH313673A patent/CH580591A5/xx not_active IP Right Cessation
- 1973-03-02 IL IL41666A patent/IL41666A/en unknown
- 1973-03-02 JP JP2444873A patent/JPS5626658B2/ja not_active Expired
- 1973-03-05 IE IE343/73A patent/IE37367B1/xx unknown
- 1973-03-05 ES ES412320A patent/ES412320A1/es not_active Expired
- 1973-03-05 CA CA165,183A patent/CA985685A/en not_active Expired
- 1973-03-05 SE SE7303018A patent/SE384206B/xx unknown
- 1973-03-05 DK DK118273A patent/DK135714C/da active
- 1973-03-06 HU HUBA2940A patent/HU167088B/hu unknown
- 1973-03-06 AT AT196973A patent/AT325614B/de not_active IP Right Cessation
- 1973-03-06 CS CS7300001590A patent/CS179980B2/cs unknown
- 1973-03-06 GB GB1075573A patent/GB1374551A/en not_active Expired
- 1973-03-06 FR FR7307920A patent/FR2183673B1/fr not_active Expired
- 1973-03-06 NL NL7303134A patent/NL7303134A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS4899180A (es) | 1973-12-15 |
| FR2183673B1 (es) | 1976-12-03 |
| GB1374551A (en) | 1974-11-20 |
| AT325614B (de) | 1975-10-27 |
| CA985685A (en) | 1976-03-16 |
| DD106832A5 (es) | 1974-07-05 |
| ES412320A1 (es) | 1976-04-16 |
| ATA196973A (de) | 1975-01-15 |
| JPS5626658B2 (es) | 1981-06-19 |
| US3876646A (en) | 1975-04-08 |
| IE37367L (en) | 1973-09-06 |
| IE37367B1 (en) | 1977-07-06 |
| IL41666A0 (en) | 1973-05-31 |
| SE384206B (sv) | 1976-04-26 |
| CS179980B2 (en) | 1977-12-30 |
| CH580591A5 (es) | 1976-10-15 |
| DK135714C (da) | 1977-11-14 |
| FR2183673A1 (es) | 1973-12-21 |
| DK135714B (da) | 1977-06-13 |
| HU167088B (es) | 1975-08-28 |
| NL7303134A (es) | 1973-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1064496A (en) | Preparation of a new cincamine salt and compound thus obtained | |
| US3826836A (en) | Phenyl-imidazolyl-fatty acid derivatives for treating mycotic infections | |
| GB1234058A (es) | ||
| IL41669A (en) | Condensed pyridine compounds their production and pharmaceutical compositions containing them | |
| JPS56128768A (en) | Substituted imidazole derivative, its manufacture and medicine as effective component | |
| US5002949A (en) | 5-substituted-6-aminopyrimidine derivatives | |
| CH627465A5 (de) | Verfahren zur herstellung von benzisothiazolonen. | |
| IL43079A (en) | 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them | |
| IE44737B1 (en) | Bis-quaternary pyridinum-2-aldoxime salts and process for their preparation | |
| US4590205A (en) | Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes | |
| GB1107470A (en) | Basic esters and a process for their production | |
| JPH01193219A (ja) | 赤血球凝固阻止作用を有する医薬 | |
| US2844510A (en) | Phosphoric acid derivatives of 1-phenyl-2, 3-dimethyl-4-amino-5-pyrazolone | |
| EP0087629A2 (en) | Antiinflammatory and/or analgesic 2,3-Diaryl-5-halo thiophenes | |
| CA1246065A (en) | 5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one | |
| KR950001040B1 (ko) | 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제 | |
| IL41666A (en) | Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them | |
| US4256752A (en) | Treatment of ulcers with acylated aminoalkyl cyanoguanidines containing a heterocyclic residue | |
| IL43063A (en) | 2-phenoxy-1-imidazolyl-alkan-3-ones their production and pharmaceutical compositions containing them | |
| IL41664A (en) | 2,6-Diamino-dihydropyridines and their pharmaceutical preparations | |
| IL42745A (en) | 2-amino-4-h-pyrane derivatives,their production and pharmaceutical compositions containing them | |
| US3103517A (en) | Z-tfflazolyl | |
| IL30706A (en) | 2-halomethyl-3-carbamoyl quinoxaline-1,4-di-n-oxides | |
| US3829422A (en) | 1,4-substituted-pyrimidin-2(1h)-ones | |
| US3725419A (en) | Quinuclidylalkyl esters |